CSO and Cofounder @ Codeable Therapeutics (April 2022 - September 2023)
CSO @ (December 2020 - March 2022)
Interim CEO and CSO @ (February 2020 - December 2020)
Independent Board Member at NBE @ (November 2016 - December 2020)
CSO and SVP @ (April 2018 - February 2020)
CSO and President @ Maverick Therapeutics, Inc. (November 2016 - March 2018)
CSO @ (September 2015 - November 2016)
Vice President @ (October 2013 - September 2015)
Executive Director @ (April 2009 - October 2013)
Director Translational Biology @ (March 2006 - April 2009)
Senior Scientist @ (March 1995 - March 2006)
Hans-Peter Gerber Education
Universität Zürich
Ph.D. In Molecular Biology (Major in Biochemistry)
1987-1995
Hans-Peter Gerber Skills
Biochemistry
Oncology
Antibodies
Drug Discovery
Therapeutics
Monoclonal Antibodies
Molecular Biology
Clinical Development
Biotechnology
Cancer
Life Sciences
Animal Models
Cell
Biopharmaceuticals
R&D
Immunology
Pharmaceutical Industry
Assay Development
Protein Chemistry
Research and Development (R&D)
Cell Culture
Business Strategy
Project Management
Microsoft Office
Data Analysis
Marketing
Genetics
Strategy
See 4+see Less
Research and Development R&d
Research and Development
Hans-Peter Gerber Summary
Hans-Peter Gerber, based in South San Francisco, CA, US, is currently a Chief Scientific Officer at Sutro Biopharma, Inc.. Hans-Peter Gerber brings experience from previous roles at T-CURX GmbH, Athebio AG, Codeable Therapeutics and 3T Biosciences. Hans-Peter Gerber holds a 1987 - 1995 Ph.D. In Molecular Biology in Major in Biochemistry @ Universität Zürich. With a robust skill set that includes Biochemistry, Oncology, Antibodies, Drug Discovery, Therapeutics and more. Hans-Peter Gerber has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Hans-Peter Gerber?
Find contact details for 700 million professionals.